Phathom Pharmaceuticals (PHAT) Non-cash Items (2019 - 2026)

Phathom Pharmaceuticals (PHAT) has 8 years of Non-cash Items data on file, last reported at $20.1 million in Q1 2026.

• Non-cash Items for Q1 2026 came in at $20.1 million, up 17.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.1 million (up 17.54% YoY), and the FY2025 annual result was $80.5 million, up 2671.5% from the prior year.
• Non-cash Items fell to $20.1 million in Q1 2026 per PHAT's latest filing, from $80.5 million in the prior quarter.
• Over five years, Non-cash Items peaked at $80.5 million in Q4 2025 and troughed at $170000.0 in Q1 2023.
• A 5-year average of $14.4 million and a median of $4.5 million in 2022 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2022 and 2024: Non-cash Items sank 92.6% in 2022, then soared 6925.88% in 2024.
• A 5-year view of Non-cash Items shows it stood at $4.5 million in 2022, then retreated by 24.51% to $3.4 million in 2023, then sank by 36.87% to $2.1 million in 2024, then jumped by 3674.45% to $80.5 million in 2025, then sank by 75.03% to $20.1 million in 2026.
• Business Quant data shows PHAT's Non-cash Items at $20.1 million in Q1 2026, $80.5 million in Q4 2025, and $4.5 million in Q3 2025.